KI’s research infrastructure and new joint research opportunities were on the agenda when Sophie Erhardt and Elham Rostami visited Mayo Clinic in Florida on 19 October. The visit was part of the strategically important partnership between Karolinska Institutet and Mayo Clinic, which dates back more than 30 years.

Photo: Christian Gustavsson
“International collaborations with leading research environments such as Mayo Clinic are important for strengthening KI’s research and creating new opportunities for our researchers. By combining our expertise and resources, we can advance research and contribute to better health, says Martin Bergö , Vice President of Karolinska Institutet.”
Research infrastructure opens up new collaborations

Photo: Martin Stenmark
Sophie Erhardt , Professor of Experimental Psychiatry and Academic Coordinator for the collaboration between KI and Mayo Clinic, and Elham Rostami , Associate Professor of Neurosurgery, neurosurgeon and Director of KI HumanLab, presented KI HumanLab and ExtremeLab at Mayo Clinic’s research meeting in Jacksonville.
KI HumanLab is established at Bioclinicum in Solna, close to Karolinska University Hospital. Researchers and clinicians from different disciplines will be able to examine the same research participant in several ways during a single visit. ExtremeLab complements the initiative with equipment to study human performance and the capacity to withstand extreme environments

Mayo Clinic Copyright
During the visit, Sophie and Elham also met the chairs and vice-chairs of the partnership’s five joint research themes. Going forward, start-up funding, known as seed grants, and travel grants will be announced to support joint research projects.
Researcher exchanges are also an important part of the collaboration. One example is doctoral student Patrik Fridh, who is spending a few weeks at Mayo Clinic in Rochester with Professor Doo-Sup Choi. There, they are studying how cellular processes and interactions between brain cells affect brain function and contribute to neurological and psychiatric diseases.
“Research reaches patients faster when it is conducted close to clinical practice. We also need an infrastructure that makes it easy for researchers to carry out their studies, says Sophie Erhardt.”
Mayo Clinic Florida is now developing its Lab of the Future, which is planned to open in 2029. During the visit, Mayo Clinic showed strong interest in how KI HumanLab has been organised and built up. Immediately after the presentation, Mayo Clinic’s consortium for research in emergency and intensive care initiated a dialogue on collaboration with the platform.
The parallel development of the research infrastructure creates opportunities to facilitate joint research from the outset.
“Mayo Clinic has a clear research strategy, and KI has prioritised areas such as precision medicine and prevention. When we develop the infrastructure in parallel, we can find ways to make the systems work together, says Sophie Erhardt.”
A partnership built on trust
Sophie Erhardt has coordinated the collaboration since 2019. She highlights shared values and personal relationships as important for ensuring that the collaboration lasts over time.
“We have a concept that we call “friendlation” – a combination of friendship and collaboration. We know and trust each other and stay in touch even when there is no finished project. This allows new ideas to emerge and continue even when people move on, says Sophie Erhardt.”
The institutions complement each other. Mayo Clinic has strong platforms for automation and data management, while KI and Karolinska University Hospital have strengths in registers, cohorts and clinical research.
Sophie also highlights Mayo Clinic’s biobank, with 6.1 million samples that researchers can search. Mayo Clinic’s research administration also uses more than 60 AI tools.
Support for joint projects and researcher exchanges

Photo: N/A
There is also an established collaboration in cancer research. Elias Arnér , Chair of Cancer Research KI (CRKI), describes it as highly rewarding. CRKI and Mayo Clinic launched a joint research programme in 2019 focusing on breast cancer. In 2022, the programme was expanded to include all forms of cancer. Between 2020 and 2025, the programme funded 16 two-year projects with a total of SEK 18.75 million. Since 2021, the parties have also organised joint symposia. The successful collaboration has now led to a call for applications for the CRKI-Mayo CCC Synergy Grant, a four-year research grant of SEK 2.5 million per year at KI, with matching funding at Mayo Clinic.
“It will be exciting to see which applications are submitted and what our continued collaboration may lead to, says Elias Arnér.”
Next steps in the collaboration
In December, an initial meeting on KI HumanLab is planned, and Mayo Clinic’s Sebastian Fernandez-Bussy and Brian Hultgren will visit KI.
Discussions on joint research areas, infrastructure and new collaborations will continue at the annual joint conference in Jacksonville on 15-16 March 2027.
About the collaboration between KI and Mayo Clinic
- The partnership covers research, education, innovation and administration.
- More than 3,000 students, researchers and staff have taken part in activities at the two institutions.
- The five joint research themes are RNA-based therapies, transplantation and regenerative medicine, cancer, biobanks and precision medicine, and brain, cardiometabolic health and immunity.